Sulfadiazine

Sulfadiazine Reactions 1680, p312 - 2 Dec 2017 Skin rash: case report A 30-year-old man developed skin rash during therapy with sulfadiazine [route and dosage not stated]. The man was hospitalised to a neurologic unit for a 5-year history of monthly frontal headache which worsened in frequency and intensity over the last month. Short-lasting episodes of sudden fall had also occurred in the past. Physical examination showed severe obesity without fever or lymphadenopathy. Brain CT scan showed multiple calcifications while MRI showed multiple cystic lesions surrounded by oedema. Toxoplasmosis serology on blood revealed a chronic infection. Total body CT showed mild splenomegaly and lymphadenopathy in the left groin. He was discharged but episodes of falling continued. Later, because of severe headache and occurrence of secondary generalised seizures, he was admitted again. Brain CT and MRI revealed a marked size increase of cystic lesions with ring enhancement; diffuse perilesional oedema with midline shift was evident. Emergency brain surgery with removal of 2 large cysts was performed. Brain tissue examination confirmed the presence of T. gondii DNA. Subsequently, antiparasitic treatment with sulfadiazine along with dexamethasone was initiated. However, after 8 days, he developed skin rash. The man’s sulfadiazine was replaced with clindamycin [outcome not stated]. Author comment: "After 8 days, sulfadiazine was replaced with clindamycin due to skin rash." Pustorino G, et al. Cerebral toxoplasmosis diagnosed by brain tissue PCR analysis in an immunocompetent patient. Neurology: Clinical Practice 7: 436-438, No. 5, Oct 2017. Available from: URL: http://doi.org/10.1212/CPJ.0000000000000364 - Italy 803285202 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Sulfadiazine

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
Free
1 page

Loading next page...
1 Page
 
/lp/springer_journal/sulfadiazine-lkfh7SsNDw
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-017-39243-3
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial